Latest Headlines

  1. Immunexpress Receives CE Mark And Signs European Commercialization Partnership For SeptiCyte® RAPID 3/27/2020

    Immunexpress, Inc. a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced it has received CE Marking of SeptiCyte® RAPID for its host response technology

  2. AnPac Bio Receives Accreditation For United States Laboratory From College Of American Pathologists 3/27/2020

    AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that its San Jose, CA lab has received accreditation from the College of American Pathologists (“CAP”)

  3. InterSystems Helps St Vincent's Pathology, Austech Medical Laboratories And Goulburn Valley Health Gear Up For COVID-19 Testing 3/27/2020

    InterSystems, a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability, and speed problems, has responded to requests from five Australian clinical laboratories gearing up to deal with COVID-19, including St Vincent’s Pathology Service, Austech Medical Laboratories, and Goulburn Valley Health Pathology

  4. Optiflux Dialyzers Show Mean Increase Of Serum Albumin In Hemodialysis Patients 3/26/2020

    Hemodialysis patients treated with Optiflux® high flux single-use dialyzers experienced a mean increase in serum albumin levels, according to results from a recent clinical trial and separate retrospective analysis conducted by Fresenius Medical Care North America

  5. Fast & Reliable Tracking Of Coronavirus Patient Samples 3/26/2020

    Ziath Ltd. has received orders for its DataPaq Mirage Rack Scanner from a growing number of laboratories that specialise in testing patient samples for Coronavirus Covid-19 infection
     

  6. Quidel’s Lyra SARS-CoV-2 Assay Receives Authorization For Expanded Use For Molecular Detection Of COVID-19; Also Receives CE Mark, Health Canada Authorization 3/25/2020

    Quidel Corporation (“Quidel”),a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel’s Lyra SARS-CoV-2 Assay has received expanded Emergency Use Authorization (EUA) claims from the Food and Drug Administration (FDA) to allow testing with three additional thermocyclers: Applied Biosystems 7500 Standard, Roche LightCycler 480, and Qiagen Rotor-Gene Q

  7. Astrotech Developing Screening Instrument For Lung Diseases Including COVID-19/Coronavirus & Pneumonia 3/25/2020

    Astrotech Corporation today announced that the BreathTest-1000 is under development to screen for volatile organic compound (VOC) metabolites found in a person’s breath that could indicate they may have an infection, including Coronavirus Disease 2019 (“COVID-19”) or the resulting disease, pneumonia

  8. First Commercial Laboratory In South Carolina Validated For COVID-19 Testing 3/24/2020

    Premier Medical Laboratory Services (PMLS), an industry leading diagnostic laboratory, headquartered in Greenville, South Carolina, is announcing today they are now validated for COVID-19 testing

  9. AnPac Bio Granted Important Novel Micro Medical Device Patent In The United States 3/24/2020

    AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today the allowance by the United States Patent and Trademark Office on March 5, 2020, of a US patent application claiming an integrated and decomposable micro apparatus that can be used for site-specific delivery of a drug, a medical kit, a micro disease detection system, or even an auto-navigation system for in vivo applications

  10. InterVenn Biosciences Adds Glycoproteomic Clinical Testing Panel For Colorectal Cancer And Advanced Adenoma 3/23/2020

    InterVenn Biosciences today announced it has added a colorectal cancer/advanced adenoma diagnostic panel to its proprietary glycoproteomic analysis platform